Adeno-associated viruses (AAV) have emerged as the lead vector in clinical trials and form the basis for several approved gene therapies for human diseases, mainly owing to their ability to sustain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback